RELX stock forecast, quote, news & analysis

Key Takeaways

• RELX PLC (RELX) shares have climbed roughly 17.6% over the past 30 days, rising from about $33.41 to approximately $39.29.
• The advance marks a sharp recovery from a September low near $32.98, reversing a period when artificial-intelligence disruption fears weighed on the stock.
• RELX's first-half 2026 results showed 7% underlying revenue growth and 9% underlying adjusted operating profit growth, with the Legal division the standout at 10% revenue growth.
• Over the last quarter, the stock has gained roughly 15%, supported by reaffirmed full-year guidance and a £2.25 billion share buyback program.
• Key watch items include adoption of AI products such as Lexis+ Protégé, Scopus AI, and LeapSpace, plus subscription renewal trends and continued capital returns.

RELX PLC (RELX) Company Overview and Market Position

RELX PLC is a London-headquartered global provider of information-based analytics and decision tools. The group operates through four divisions: Risk, its largest business, which supplies data and analytics for financial crime compliance, fraud and identity solutions, and insurance; Scientific, Technical & Medical, which operates as Elsevier and includes ScienceDirect, Scopus, and clinical decision-support tools; Legal, which trades as LexisNexis and provides legal research, analytics, and workflow software; and Exhibitions, which runs trade shows under the RX brand.

Most of RELX's revenue is recurring, derived from subscriptions and usage-linked transactional fees, which has historically supported predictable earnings and widening margins. The company's US-listed shares trade under the RELX ticker, while its primary listing is on the London Stock Exchange. Investors follow the stock closely because of its operating leverage, its proprietary datasets, and its increasingly central role in applying generative AI across professional, legal, and scientific markets.

RELX PLC (RELX) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, RELX shares have risen from a closing price of $33.41 on September 18, 2026, to approximately $39.29 as of mid-October 2026, a gain of roughly 17.6%. The move was not a straight line: the stock bottomed near $32.98 in late September before accelerating sharply in the first half of October.

The quarterly picture tells a similar but more volatile story. Around mid-July, RELX traded near $34.10, meaning the stock has gained roughly 15% over the last three months. That net advance conceals a meaningful round trip, however. Shares initially rallied after strong first-half results in late July, pulled back through September as AI-disruption concerns resurfaced across the information-services sector, and then recovered in October. The result is that RELX has now recaptured much of the ground lost during the sector-wide de-rating earlier in 2026.

What Drove RELX Stock Price in the Last 30 Days

The 30-day rebound reflects a shift in sentiment rather than a single discrete event. For much of 2026, RELX traded under pressure from investor fears that large language models could erode the pricing power of specialist information providers; in early September the shares were down double digits year-to-date despite solid operating results. Through October, those concerns began to ease as investors reassessed the evidence that AI is accelerating, rather than undermining, RELX's growth.

That reassessment is grounded in fundamentals. In its first-half results, reported on July 23, 2026, RELX delivered £4,871 million in revenue, up 7% on an underlying basis, and £1,727 million in adjusted operating profit, up 9% on an underlying basis. The adjusted operating margin improved to 35.5% from 34.8%. Legal was the strongest division, with underlying revenue growth of 10% and profit growth of 13%, driven by the Lexis+ platform and the Protégé agentic legal assistant. Management reaffirmed its full-year outlook for strong underlying growth in revenue, adjusted operating profit, and adjusted earnings per share.

What Drove RELX Stock Performance Over the Last Quarter

The last three months reflect a broader narrative about AI and professional data. RELX's July interim results showed accelerating momentum across all four divisions, with Risk growing revenue 8%, Scientific, Technical & Medical 6%, Legal 10%, and Exhibitions 6% on an underlying basis. Management attributed the improving trajectory to a continuing shift in business mix toward higher-growth analytics and decision tools, supported by AI-enabled products such as Scopus AI, Sherpath AI, and the newly launched LeapSpace research workspace.

Despite that strength, the shares slid through September as general-purpose AI tools continued to dominate market debate around information and analytics companies. The October recovery suggests investors are increasingly crediting RELX's argument that trusted, proprietary content becomes more valuable when paired with AI. Ongoing execution of the £2.25 billion share buyback, of which £1.75 billion was completed in the first half, has also provided support to the shares.

Trending AI Robots

Tickeron's Trending AI Robots page offers a curated view of AI-powered trading bots that are actively trading across thousands of tickers. While the platform hosts hundreds of bots, only the top-performing and most relevant ones are featured in this section, making it a practical starting point for traders who want to filter out the noise. These bots vary widely in strategy, trading timeframe, and performance metrics, so users can compare approaches ranging from short-term momentum to longer-horizon signals. For investors tracking names like RELX and monitoring shifting market sentiment, exploring the Trending AI Robots section can provide a data-driven way to observe how automated strategies are positioning across the market.

RELX Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, the most important factor for RELX will be whether AI-enabled products translate into sustained revenue growth and pricing power without cannibalizing existing subscriptions. Adoption of Lexis+ with Protégé in Legal, and Scopus AI and LeapSpace in Scientific, Technical & Medical, will be closely watched, as will renewal rates in subscription businesses that account for a large share of revenue.

Investors will also monitor the completion of the remaining share buyback, any further bolt-on acquisitions, and currency effects, since much of RELX's revenue is earned in US dollars. Broader macroeconomic conditions and the pace of sector rotation into or out of information-services names may continue to influence short-term price action. RELX's next scheduled update and full-year guidance will provide further evidence on whether the recent momentum in Legal, Risk, and STM is durable.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations